‌

US Patent 10047165 Compositions for inhibiting MASP-2 dependent complement activation

Patent 10047165 was granted and assigned to Omeros (company) on August, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Omeros (company)

Current Assignee

Omeros (company)

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

100471650

Patent Inventor Names

James Brian Parent0

Thomas Dudler0

Sergej Kiprijanov0

Wayne R. Gombotz0

Urs Beat Hagemann0

Anita Kavlie0

Clark E. Tedford0

Herald Reiersen0

Date of Patent

August 14, 2018

Patent Application Number

152638760

Date Filed

September 13, 2016

Patent Primary Examiner

‌

Zachary S Skelding

Patent abstract

The present invention relates to anti-MASP-2 inhibitory antibodies and compositions comprising such antibodies for use in inhibiting the adverse effects of MASP-2 dependent complement activation.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10047165 Compositions for inhibiting MASP-2 dependent complement activation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API